Literature DB >> 18005343

Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus.

M T Tebano1, A Martire, R L Potenza, C Grò, R Pepponi, M Armida, M R Domenici, M A Schwarzschild, J F Chen, P Popoli.   

Abstract

Brain-derived neurotrophic factor (BDNF), a member of neurotrophin family, enhances synaptic transmission and regulates neuronal proliferation and survival. Both BDNF and its tyrosine kinase receptors (TrkB) are highly expressed in the hippocampus, where an interaction with adenosine A(2A) receptors (A(2A)Rs) has been recently reported. In the present paper, we evaluated the role of A(2A)Rs in mediating functional effects of BDNF in hippocampus using A(2A)R knock-out (KO) mice. In hippocampal slices from WT mice, application of BDNF (10 ng/mL) increased the slope of excitatory post-synaptic field potentials (fEPSPs), an index of synaptic facilitation. This increase of fEPSP slope was abolished by the selective A(2A) antagonist ZM 241385. Similarly, genetic deletion of the A(2A)Rs abolished BDNF-induced increase of the fEPSP slope in slices from A(2A)R KO mice The reduced functional ability of BDNF in A(2A)R KO mice was correlated with the reduction in hippocampal BDNF levels. In agreement, the pharmacological blockade of A(2)Rs by systemic ZM 241385 significantly reduced BDNF levels in the hippocampus of normal mice. These results indicate that the tonic activation of A(2A)Rs is required for BDNF-induced potentiation of synaptic transmission and for sustaining a normal BDNF tone in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005343     DOI: 10.1111/j.1471-4159.2007.05046.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  33 in total

1.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 2.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 3.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

4.  Brain-derived neurotrophic factor (BDNF) enhances GABA transport by modulating the trafficking of GABA transporter-1 (GAT-1) from the plasma membrane of rat cortical astrocytes.

Authors:  Sandra H Vaz; Trine N Jørgensen; Sofia Cristóvão-Ferreira; Sylvie Duflot; Joaquim A Ribeiro; Ulrik Gether; Ana M Sebastião
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

5.  Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase.

Authors:  Maria José Diógenes; Raquel Neves-Tomé; Sergio Fucile; Katiuscia Martinello; Maria Scianni; Panos Theofilas; Jan Lopatár; Joaquim A Ribeiro; Laura Maggi; Bruno G Frenguelli; Cristina Limatola; Detlev Boison; Ana M Sebastião
Journal:  Cereb Cortex       Date:  2012-09-20       Impact factor: 5.357

6.  Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.

Authors:  Clotilde Lauro; Raffaela Cipriani; Myriam Catalano; Flavia Trettel; Giuseppina Chece; Valentina Brusadin; Letizia Antonilli; Nico van Rooijen; Fabrizio Eusebi; Bertil B Fredholm; Cristina Limatola
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

7.  Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain.

Authors:  Catherine J Wei; Elisabete Augusto; Catarina A Gomes; Philipp Singer; Yumei Wang; Detlev Boison; Rodrigo A Cunha; Benjamin K Yee; Jiang-Fan Chen
Journal:  Biol Psychiatry       Date:  2013-06-29       Impact factor: 13.382

8.  Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay.

Authors:  Peter H Reinhart; Linda S Kaltenbach; Christian Essrich; Denise E Dunn; Joshua A Eudailey; C Todd DeMarco; Gregory J Turmel; Jennifer C Whaley; Andrew Wood; Seongeun Cho; Donald C Lo
Journal:  Neurobiol Dis       Date:  2011-03-31       Impact factor: 5.996

9.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.